Thinking about mixing your own semaglutide? Read this first

Licensed semaglutide (Wegovy) comes as a factory-sealed, sterile, pre-filled pen, no mixing, measuring or reconstitution is needed or safe to replicate at home.
Raw semaglutide powder sold online has no MHRA quality assurance; purity, sterility and concentration cannot be verified without laboratory testing.
Injecting an incorrectly prepared solution risks infection, dosing errors and unknown contaminants, harms the MHRA has flagged in public warnings about unlicensed weight-loss products.
The only legal route to semaglutide for weight loss in the UK is a prescription from a qualified prescriber, dispensed through a GPhC-registered pharmacy.

Mixing your own semaglutide means combining raw or powdered semaglutide with a diluent yourself, outside any regulated manufacturing process. This practice — sometimes called compounding or self-mixing — carries serious safety risks and sits outside the UK's licensed medicines framework. Semaglutide for weight management is only legally available in the UK as a licensed prescription medicine, assessed by a registered prescriber, dispensed by a regulated pharmacy. If you've come across instructions online for how to do this at home, the information below will help you weigh what that actually means.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Why people consider it, what the risks actually are, and what the licensed alternative looks like

The decision many people are actually facing

Cost is usually the driver. Wegovy has a real price tag in private practice, and when someone spots a vial of powder labelled "semaglutide" selling online for a fraction of the cost, the arithmetic can seem appealing. There's a widespread assumption (gently let go here) that the active ingredient is what matters, and that the branded version is just packaging. In reality, what you're paying for in a licensed medicine includes manufacturing to pharmaceutical-grade sterility standards, independent quality testing, a precise and verified dose in every injection, stability data across the product's shelf life, and a pharmacovigilance system that tracks safety in the real world. A powder in a vial has none of those assurances attached to it.

If the cost of licensed treatment is the sticking point, the Wegovy price comparison page sets out what private providers typically charge and what a transparent price should include, which is a more useful comparison than weighing a licensed pen against an unverified powder.

What "self-mixing" involves and where it goes wrong

The process described in online guides typically involves reconstituting lyophilised (freeze-dried) peptide powder with bacteriostatic water, drawing the solution into a syringe, and injecting subcutaneously. Each of those steps carries risk. Bacteriostatic water itself must be pharmaceutical grade and correctly stored. The powder's stated concentration may not match its actual content. Reconstitution changes stability; once mixed, the solution must be handled, stored and used within a narrow window. Without a laminar flow hood, sterile technique and laboratory verification, contamination is not a theoretical concern, it is probable over repeated doses. Our guide to self-mix semaglutide explains in detail why each stage of this process is far more hazardous in practice than online instructions suggest.

There is more on the specific hazards of home preparation at our page on whether making your own semaglutide is possible, and separately a detailed look at what semaglutide should not be mixed with even in clinical settings. Neither page makes reassuring reading for the home-mixing approach.

The regulatory picture in the UK

Semaglutide is a prescription-only medicine under the Human Medicines Regulations 2012. That status means it can only be legally supplied following a valid prescription from a registered prescriber. Unlicensed compounding of prescription medicines for individual patients does exist in UK pharmacy practice, but it is tightly governed, it requires a licensed specials manufacturer or a pharmacy operating under a Specials licence, with robust quality systems. Kitchen reconstitution has no legal standing in that framework.

The MHRA has issued clear public warnings about unsafe fake and unlicensed weight-loss products circulating online, and their Yellow Card scheme allows anyone to report suspected unsafe products or sellers. The NHS summarises what patients should expect from a licensed semaglutide product on the NHS semaglutide medicines page, it's a useful reference for understanding what a genuine, regulated product looks like.

If you'd like to understand how semaglutide works as a licensed treatment, the semaglutide overview covers the mechanism, the evidence and the licensed strengths in plain language.

What the licensed route actually looks like in practice

Wegovy, the licensed semaglutide injection for weight management, comes as a pre-filled pen. There is nothing to mix, measure or draw up. The dose is set, the needle is pre-attached, and the pen is ready to use after a brief review of the patient information leaflet. It is refrigerated between uses (stored like any other medicine) and injected once a week into the abdomen, thigh or upper arm.

Starting treatment through a regulated private pharmacy like nume means a qualified prescriber reviews your health information personally before any medicine is issued. Our clinical team, led by our Independent Prescriber, assesses every consultation on the same day it arrives. If treatment is clinically suitable, it is dispensed from our GPhC-registered pharmacy (registration 9012878, verifiable at the GPhC register) and delivered the next working day by DPD in plain packaging. The Wegovy treatment page has full details on the licensed pen, the dose schedule and what to expect. If you have questions before starting, the FAQs cover the most common ones, and the weight-loss treatment overview explains where Wegovy sits alongside other options.

For anyone seriously considering weight management treatment, a conversation with a prescriber is the right starting point. Speak to our prescribers through a free consultation, no obligation, and everything is reviewed the same day.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions